Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Dechun Feng

Showing results (1-10 of 116) with videos related to

Pageof 12
Sort By:
Hepatology (Baltimore, Md.)|December 6, 2013
Interleukin-22, liver progenitor cells, and liver cancerDechun Feng
Cellular & Molecular Immunology|December 19, 2020
From basic liver immunology to therapeutic opportunities for liver diseasesDechun Feng, Bin Gao
Hepatology (Baltimore, Md.)|January 29, 2008
Lipid accumulation in concanavalin A-induced hepatitis: Another cause for impaired liver regeneration afterwards?Dechun Feng, Lingyun Xu
Theranostics|July 21, 2020
Interleukin-22 acts as a mitochondrial protectorSeonghwan Hwang, Dechun Feng, Bin Gao
Hepatology (Baltimore, Md.)|April 14, 2015
ReplyDechun Feng, Mingjiang Xu, Bin Gao
Hepatology (Baltimore, Md.)|June 9, 2015
ReplyMingjiang Xu, Dechun Feng, Bin Gao
Hepatology (Baltimore, Md.)|January 29, 2008
Leptin, a possible cause for regulatory T cell loss in fatty liver?Dechun Feng, Feng Zhou, Chuanfeng Wu
Journal of Hepatology|April 5, 2026
IL-22 unlocks large-scale in vitro hepatocyte expansion via STAT3 activationDechun Feng, Robim M Rodrigues, Bin Gao
Mediators of Inflammation|April 6, 2018
Inflammation in Liver DiseasesDechun Feng, Partha Mukhopadhyay, Ju Qiu, et al.
Journal of Gastroenterology and Hepatology|July 17, 2013
Hepatoprotective and anti-fibrotic functions of interleukin-22: therapeutic potential for the treatment of alcoholic liver diseaseXiaoni Kong, Dechun Feng, Stephanie Mathews, et al.
Pageof 12

Showing results (1-10 of 116) with videos related to

Sort By:
Pageof 12
Hepatology (Baltimore, Md.)|December 6, 2013
Interleukin-22, liver progenitor cells, and liver cancerDechun Feng
Cellular & Molecular Immunology|December 19, 2020
From basic liver immunology to therapeutic opportunities for liver diseasesDechun Feng, Bin Gao
Hepatology (Baltimore, Md.)|January 29, 2008
Lipid accumulation in concanavalin A-induced hepatitis: Another cause for impaired liver regeneration afterwards?Dechun Feng, Lingyun Xu
Theranostics|July 21, 2020
Interleukin-22 acts as a mitochondrial protectorSeonghwan Hwang, Dechun Feng, Bin Gao
Hepatology (Baltimore, Md.)|April 14, 2015
ReplyDechun Feng, Mingjiang Xu, Bin Gao
Hepatology (Baltimore, Md.)|June 9, 2015
ReplyMingjiang Xu, Dechun Feng, Bin Gao
Hepatology (Baltimore, Md.)|January 29, 2008
Leptin, a possible cause for regulatory T cell loss in fatty liver?Dechun Feng, Feng Zhou, Chuanfeng Wu
Journal of Hepatology|April 5, 2026
IL-22 unlocks large-scale in vitro hepatocyte expansion via STAT3 activationDechun Feng, Robim M Rodrigues, Bin Gao
Mediators of Inflammation|April 6, 2018
Inflammation in Liver DiseasesDechun Feng, Partha Mukhopadhyay, Ju Qiu, et al.
Journal of Gastroenterology and Hepatology|July 17, 2013
Hepatoprotective and anti-fibrotic functions of interleukin-22: therapeutic potential for the treatment of alcoholic liver diseaseXiaoni Kong, Dechun Feng, Stephanie Mathews, et al.
Pageof 12